SEC 13F Intelligence

Siguler Guff Advisers, LLC / RPRX

Siguler Guff Advisers, LLC’s Royalty Pharma PLC Position

Does Siguler Guff Advisers, LLC own Royalty Pharma PLC (RPRX)? Not currently — the last reported position was 2.37M shares worth $60M in Q4 2024; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$60M
Q4 2024
Shares
2.37M
% of Portfolio
+30.11%
Quarters Held
8
position exited

Position History RPRX

Reported value by quarter
Q1 ’23: $122MQ1 ’23Q2 ’23: $104MQ2 ’23Q3 ’23: $92MQ3 ’23Q4 ’23: $95MQ4 ’23Q1 ’24: $103MQ1 ’24Q2 ’24: $89MQ2 ’24Q3 ’24: $96MQ3 ’24Q4 ’24: $60MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20242.37M$60M+30.11%
Q3 20243.39M$96M+35.68%
Q2 20243.39M$89M+38.31%
Q1 20243.39M$103M+41.04%
Q4 20233.39M$95M+38.07%
Q3 20233.39M$92M+47.04%
Q2 20233.39M$104M+46.16%
Q1 20233.39M$122M+47.65%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Siguler Guff Advisers, LLC’s full portfolio or all institutional holders of RPRX.